MDM2 and meningioma: Notably, one of the patients (GU-hgMNG-14) showed heterogeneous amplification of the proto-oncogene MDM2. The occurrence of MDM2 amplification is a rare genomic alteration in atypical meningiomas associated with the malignant pathogenesis of the tumor50,51.